The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Prenatal Screening Market Research Report 2024
Synopsis
The global Prenatal Screening market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Prenatal Screening is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Prenatal Screening is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Prenatal Screening in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Prenatal Screening include Laboratory Corporation of America Holdings, Sequenom, Quest Diagnostics, Illumina, GeneDx, Ariosa Diagnostics, Natera, Ravgen and Counsyl, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Prenatal Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prenatal Screening.
Report Scope
The Prenatal Screening market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prenatal Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prenatal Screening companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Laboratory Corporation of America Holdings
Sequenom
Quest Diagnostics
Illumina
GeneDx
Ariosa Diagnostics
Natera
Ravgen
Counsyl
Eurofins NTD
Premaitha Health
Prenatal Paternities
Segment by Type
First-Trimester Screening Tests
Second-Trimester Screening Tests
Third-Trimester Screening Tests
Diagnostic Tests
Segment by Application
Hospitals
Gynecology Clinics
Research Organizations
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prenatal Screening companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Prenatal Screening market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Prenatal Screening is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Prenatal Screening is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Prenatal Screening in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Prenatal Screening include Laboratory Corporation of America Holdings, Sequenom, Quest Diagnostics, Illumina, GeneDx, Ariosa Diagnostics, Natera, Ravgen and Counsyl, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Prenatal Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prenatal Screening.
Report Scope
The Prenatal Screening market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prenatal Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prenatal Screening companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Laboratory Corporation of America Holdings
Sequenom
Quest Diagnostics
Illumina
GeneDx
Ariosa Diagnostics
Natera
Ravgen
Counsyl
Eurofins NTD
Premaitha Health
Prenatal Paternities
Segment by Type
First-Trimester Screening Tests
Second-Trimester Screening Tests
Third-Trimester Screening Tests
Diagnostic Tests
Segment by Application
Hospitals
Gynecology Clinics
Research Organizations
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prenatal Screening companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prenatal Screening Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 First-Trimester Screening Tests
1.2.3 Second-Trimester Screening Tests
1.2.4 Third-Trimester Screening Tests
1.2.5 Diagnostic Tests
1.3 Market by Application
1.3.1 Global Prenatal Screening Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Gynecology Clinics
1.3.4 Research Organizations
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prenatal Screening Market Perspective (2019-2030)
2.2 Prenatal Screening Growth Trends by Region
2.2.1 Global Prenatal Screening Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Prenatal Screening Historic Market Size by Region (2019-2024)
2.2.3 Prenatal Screening Forecasted Market Size by Region (2025-2030)
2.3 Prenatal Screening Market Dynamics
2.3.1 Prenatal Screening Industry Trends
2.3.2 Prenatal Screening Market Drivers
2.3.3 Prenatal Screening Market Challenges
2.3.4 Prenatal Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prenatal Screening Players by Revenue
3.1.1 Global Top Prenatal Screening Players by Revenue (2019-2024)
3.1.2 Global Prenatal Screening Revenue Market Share by Players (2019-2024)
3.2 Global Prenatal Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prenatal Screening Revenue
3.4 Global Prenatal Screening Market Concentration Ratio
3.4.1 Global Prenatal Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prenatal Screening Revenue in 2023
3.5 Prenatal Screening Key Players Head office and Area Served
3.6 Key Players Prenatal Screening Product Solution and Service
3.7 Date of Enter into Prenatal Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prenatal Screening Breakdown Data by Type
4.1 Global Prenatal Screening Historic Market Size by Type (2019-2024)
4.2 Global Prenatal Screening Forecasted Market Size by Type (2025-2030)
5 Prenatal Screening Breakdown Data by Application
5.1 Global Prenatal Screening Historic Market Size by Application (2019-2024)
5.2 Global Prenatal Screening Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Prenatal Screening Market Size (2019-2030)
6.2 North America Prenatal Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Prenatal Screening Market Size by Country (2019-2024)
6.4 North America Prenatal Screening Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prenatal Screening Market Size (2019-2030)
7.2 Europe Prenatal Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Prenatal Screening Market Size by Country (2019-2024)
7.4 Europe Prenatal Screening Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prenatal Screening Market Size (2019-2030)
8.2 Asia-Pacific Prenatal Screening Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Prenatal Screening Market Size by Region (2019-2024)
8.4 Asia-Pacific Prenatal Screening Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prenatal Screening Market Size (2019-2030)
9.2 Latin America Prenatal Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Prenatal Screening Market Size by Country (2019-2024)
9.4 Latin America Prenatal Screening Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prenatal Screening Market Size (2019-2030)
10.2 Middle East & Africa Prenatal Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Prenatal Screening Market Size by Country (2019-2024)
10.4 Middle East & Africa Prenatal Screening Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Laboratory Corporation of America Holdings
11.1.1 Laboratory Corporation of America Holdings Company Detail
11.1.2 Laboratory Corporation of America Holdings Business Overview
11.1.3 Laboratory Corporation of America Holdings Prenatal Screening Introduction
11.1.4 Laboratory Corporation of America Holdings Revenue in Prenatal Screening Business (2019-2024)
11.1.5 Laboratory Corporation of America Holdings Recent Development
11.2 Sequenom
11.2.1 Sequenom Company Detail
11.2.2 Sequenom Business Overview
11.2.3 Sequenom Prenatal Screening Introduction
11.2.4 Sequenom Revenue in Prenatal Screening Business (2019-2024)
11.2.5 Sequenom Recent Development
11.3 Quest Diagnostics
11.3.1 Quest Diagnostics Company Detail
11.3.2 Quest Diagnostics Business Overview
11.3.3 Quest Diagnostics Prenatal Screening Introduction
11.3.4 Quest Diagnostics Revenue in Prenatal Screening Business (2019-2024)
11.3.5 Quest Diagnostics Recent Development
11.4 Illumina
11.4.1 Illumina Company Detail
11.4.2 Illumina Business Overview
11.4.3 Illumina Prenatal Screening Introduction
11.4.4 Illumina Revenue in Prenatal Screening Business (2019-2024)
11.4.5 Illumina Recent Development
11.5 GeneDx
11.5.1 GeneDx Company Detail
11.5.2 GeneDx Business Overview
11.5.3 GeneDx Prenatal Screening Introduction
11.5.4 GeneDx Revenue in Prenatal Screening Business (2019-2024)
11.5.5 GeneDx Recent Development
11.6 Ariosa Diagnostics
11.6.1 Ariosa Diagnostics Company Detail
11.6.2 Ariosa Diagnostics Business Overview
11.6.3 Ariosa Diagnostics Prenatal Screening Introduction
11.6.4 Ariosa Diagnostics Revenue in Prenatal Screening Business (2019-2024)
11.6.5 Ariosa Diagnostics Recent Development
11.7 Natera
11.7.1 Natera Company Detail
11.7.2 Natera Business Overview
11.7.3 Natera Prenatal Screening Introduction
11.7.4 Natera Revenue in Prenatal Screening Business (2019-2024)
11.7.5 Natera Recent Development
11.8 Ravgen
11.8.1 Ravgen Company Detail
11.8.2 Ravgen Business Overview
11.8.3 Ravgen Prenatal Screening Introduction
11.8.4 Ravgen Revenue in Prenatal Screening Business (2019-2024)
11.8.5 Ravgen Recent Development
11.9 Counsyl
11.9.1 Counsyl Company Detail
11.9.2 Counsyl Business Overview
11.9.3 Counsyl Prenatal Screening Introduction
11.9.4 Counsyl Revenue in Prenatal Screening Business (2019-2024)
11.9.5 Counsyl Recent Development
11.10 Eurofins NTD
11.10.1 Eurofins NTD Company Detail
11.10.2 Eurofins NTD Business Overview
11.10.3 Eurofins NTD Prenatal Screening Introduction
11.10.4 Eurofins NTD Revenue in Prenatal Screening Business (2019-2024)
11.10.5 Eurofins NTD Recent Development
11.11 Premaitha Health
11.11.1 Premaitha Health Company Detail
11.11.2 Premaitha Health Business Overview
11.11.3 Premaitha Health Prenatal Screening Introduction
11.11.4 Premaitha Health Revenue in Prenatal Screening Business (2019-2024)
11.11.5 Premaitha Health Recent Development
11.12 Prenatal Paternities
11.12.1 Prenatal Paternities Company Detail
11.12.2 Prenatal Paternities Business Overview
11.12.3 Prenatal Paternities Prenatal Screening Introduction
11.12.4 Prenatal Paternities Revenue in Prenatal Screening Business (2019-2024)
11.12.5 Prenatal Paternities Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
